1. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018;Foster;Diabetes Technol Ther,2019
2. Compatibility and safety of ultra rapid lispro with continuous subcutaneous insulin infusion in patients with type 1 diabetes: PRONTO-pump study;Bode;Diabetes Technol Ther,2021
3. Novo Nordisk. NovoLog, insulin aspart injection 100 units/mL, NovoNordisk. Prescribing information, revised: 10/2021. Available at: https://www.novo-pi.com/novolog.pdf. Accessed April 10, 2022.
4. European Medicines Agency. NovoRapid. Summary of product characteristics, 23 November 2020. Available at:https://www.ema.europa.eu/documents/product-information/novorapid-epar-product-information_en.pdf. Accessed March 2, 2021.
5. Insulin aspart in the management of diabetes mellitus: 15 years of clinical experience;Hermansen;Drugs,2016